During a cervical cancer screening program in a primary health center in Tamil Nadu, a 42-year-old woman with no prior screening history undergoes Pap smear. The result shows 'atypical squamous cells of undetermined significance' (ASC-US). She is asymptomatic with no abnormal vaginal discharge. What is the most appropriate next step in management?

## Screening Context This question addresses the management of an equivocal Pap smear result (ASC-US) in a screening program. The challenge is to identify which women with ASC-US have underlying cervical intraepithelial neoplasia (CIN) or cancer without over-referring for colposcopy. ## ASC-US: Definition and Significance **Key Point:** ASC-US is the most common abnormal Pap smear result, affecting 1–3% of screened women. Approximately 15–30% of ASC-US cases harbor CIN 2 or higher lesions, while 70–85% are benign. **High-Yield:** The 2012 ASCCP (American Society for Colposcopy and Cervical Pathology) guidelines, adopted by most screening programs including India, recommend reflex HPV testing for ASC-US as the preferred triage strategy. ## Management Algorithm for ASC-US ```mermaid flowchart TD A[ASC-US on Pap smear]:::outcome --> B{Reflex HPV testing}:::decision B -->|HPV negative| C[Return to routine screening]:::action B -->|HPV positive| D[Refer for colposcopy]:::action C --> E[Repeat Pap in 3 years]:::action D --> F{Colposcopy findings}:::decision F -->|Normal| G[Routine follow-up]:::action F -->|CIN 1 or higher| H[Treatment/further management]:::action ``` ## Why Reflex HPV Testing? | Strategy | Sensitivity for CIN 2+ | Specificity | Advantage | Disadvantage | |----------|------------------------|-------------|-----------|---------------| | Repeat Pap in 12 months | 95% | Low | Reduces overtreatment | Delays diagnosis, compliance issues | | Reflex HPV testing | 95% | 60–70% | Identifies high-risk women, single visit | Some HPV+ women have benign disease | | Immediate colposcopy | 90% | 50% | Definitive diagnosis | Overtreatment, unnecessary procedures | **Clinical Pearl:** HPV testing on the same specimen (reflex testing) is cost-effective and efficient because: - HPV-negative women (70–85% of ASC-US) can return to routine screening - HPV-positive women (15–30% of ASC-US) proceed to colposcopy - Avoids unnecessary colposcopy in the majority of women - Single visit reduces loss to follow-up **Key Point:** HPV persistence (not transient infection) is the key driver of cervical cancer risk. Women with ASC-US and negative HPV have <1% risk of CIN 2+ and can safely return to routine screening. ## Screening Principle Triage strategies in screening programs must balance sensitivity (detecting disease) with specificity (avoiding unnecessary procedures). Reflex HPV testing achieves this balance for ASC-US.